{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:23:23Z","timestamp":1770290603833,"version":"3.49.0"},"publisher-location":"Cham","reference-count":102,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319173436","type":"print"},{"value":"9783319173443","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-17344-3_5","type":"book-chapter","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T14:07:11Z","timestamp":1436191631000},"page":"117-134","source":"Crossref","is-referenced-by-count":14,"title":["Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A"],"prefix":"10.1007","author":[{"given":"Wilfredo","family":"Col\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Javier","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saipraveen","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2014.05.007","volume":"104","author":"JJ Aguilera","year":"2014","unstructured":"Aguilera JJ, Zhang F, Beaudet JM, Linhardt RJ, Colon W (2014) Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A. Biochimie 104:70\u201380","journal-title":"Biochimie"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1074\/jbc.274.11.7172","volume":"274","author":"JB Ancsin","year":"1999","unstructured":"Ancsin JB, Kisilevsky R (1999) The heparin\/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis. J Biol Chem 274:7172\u20137181","journal-title":"J Biol Chem"},{"key":"5_CR3","first-page":"139","volume":"47","author":"MA Axelrad","year":"1982","unstructured":"Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M (1982) Further characterization of amyloid-enhancing factor. Lab Invest 47:139\u2013146","journal-title":"Lab Invest"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.74.9.4025","volume":"74","author":"EP Benditt","year":"1977","unstructured":"Benditt EP, Eriksen N (1977) Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci U S A 74:4025\u20134028","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/bi101822y","volume":"50","author":"S Bourgault","year":"2011","unstructured":"Bourgault S, Solomon JP, Reixach N, Kelly JW (2011) Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion. Biochemistry 50:1001\u20131015","journal-title":"Biochemistry"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nsb963","volume":"10","author":"S Breinig","year":"2003","unstructured":"Breinig S, Kervinen J, Stith L, Wasson AS, Fairman R, Wlodawer A, Zdanov A, Jaffe EK (2003) Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase. Nat Struct Biol 10:757\u2013763","journal-title":"Nat Struct Biol"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/13506120009146246","volume":"7","author":"TF Chung","year":"2000","unstructured":"Chung TF, Sipe JD, McKee A, Fine RE, Schreiber BM, Liang JS, Johnson RJ (2000) Serum amyloid A in Alzheimer\u2019s disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid 7:105\u2013110","journal-title":"Amyloid"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jmb.2010.04.006","volume":"399","author":"AJ Cross","year":"2010","unstructured":"Cross AJ, Jeffries CM, Trewhella J, Matthews JM (2010) LIM domain binding proteins 1 and 2 have different oligomeric states. J Mol Biol 399:133\u2013144","journal-title":"J Mol Biol"},{"key":"5_CR9","doi-asserted-by":"crossref","unstructured":"Cuanalo-Contreras K, Mukherjee A, Soto C (2013) Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int J Cell Biol 2013:1\u201310","DOI":"10.1155\/2013\/638083"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002281-200101000-00011","volume":"13","author":"G Cunnane","year":"2001","unstructured":"Cunnane G (2001) Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol 13:67\u201373","journal-title":"Curr Opin Rheumatol"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"20606","DOI":"10.1016\/S0021-9258(20)80768-6","volume":"268","author":"MC Beer de","year":"1993","unstructured":"de Beer MC, de Beer FC, McCubbin WD, Kay CM, Kindy MS (1993) Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 268:20606\u201320612","journal-title":"J Biol Chem"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"e03206","DOI":"10.7554\/eLife.03206","volume":"3","author":"MG Derebe","year":"2014","unstructured":"Derebe MG, Zlatkov CM, Gattu S, Ruhn KA, Vaishnava S, Diehl GE, MacMillan JB, Williams NS, Hooper LV (2014) Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection. Elife 3:e03206","journal-title":"Elife"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2011.04.019","volume":"511","author":"M Egashira","year":"2011","unstructured":"Egashira M, Takase H, Yamamoto I, Tanaka M, Saito H (2011) Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides. Arch Biochem Biophys 511:101\u2013106","journal-title":"Arch Biochem Biophys"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","volume":"32","author":"KK Eklund","year":"2012","unstructured":"Eklund KK, Niemi K, Kovanen PT (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32:335\u2013348","journal-title":"Crit Rev Immunol"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1096\/fj.03-1436fje","volume":"18","author":"E Elimova","year":"2004","unstructured":"Elimova E, Kisilevsky R, Szarek WA, Ancsin JB (2004) Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J 18:1749\u20131751","journal-title":"FASEB J"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.09-134981","volume":"23","author":"E Elimova","year":"2009","unstructured":"Elimova E, Kisilevsky R, Ancsin JB (2009) Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB J 23:3436\u20133448","journal-title":"FASEB J"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-5793(87)81008-6","volume":"218","author":"LH Ericsson","year":"1987","unstructured":"Ericsson LH, Eriksen N, Walsh KA, Benditt EP (1987) Primary structure of duck amyloid protein A. The form deposited in tissues may be identical to its serum precursor. FEBS Lett 218:11\u201316","journal-title":"FEBS Lett"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448\u2013454","journal-title":"N Engl J Med"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","volume":"358","author":"JD Gillmore","year":"2001","unstructured":"Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24\u201329","journal-title":"Lancet"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bcp.2013.12.023","volume":"88","author":"MJ Guerrero-Munoz","year":"2014","unstructured":"Guerrero-Munoz MJ, Castillo-Carranza DL, Kayed R (2014) Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins. Biochem Pharmacol 88:468\u2013478","journal-title":"Biochem Pharmacol"},{"key":"5_CR21","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.22-14-05900.2002","volume":"22","author":"JT Guo","year":"2002","unstructured":"Guo JT, Yu J, Grass D, de Beer FC, Kindy MS (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 22:5900\u20135909","journal-title":"J Neurosci"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.59.8.577","volume":"59","author":"BP Hazenberg","year":"2000","unstructured":"Hazenberg BP, van Rijswijk MH (2000) Where has secondary amyloid gone? Ann Rheum Dis 59:577\u2013579","journal-title":"Ann Rheum Dis"},{"key":"5_CR23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.159.2.641","volume":"159","author":"JS Hoffman","year":"1984","unstructured":"Hoffman JS, Ericsson LH, Eriksen N, Walsh KA, Benditt EP (1984) Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 159:641\u2013646","journal-title":"J Exp Med"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/030097498440750","volume":"27","author":"G Husby","year":"1998","unstructured":"Husby G (1998) Treatment of amyloidosis and the rheumatologist. State of the art and perspectives for the future. Scand J Rheumatol 27:161\u2013165","journal-title":"Scand J Rheumatol"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-3083.1985.tb01431.x","volume":"21","author":"A Husebekk","year":"1985","unstructured":"Husebekk A, Skogen B, Husby G, Marhaug G (1985) Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 21:283\u2013287","journal-title":"Scand J Immunol"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/13506129.2010.549252","volume":"18","author":"K Immonen","year":"2011","unstructured":"Immonen K, Finne P, Gronhagen-Riska C, Pettersson T, Klaukka T, Kautiainen H, Hakala M (2011) A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases \u2013 data from nationwide registries in Finland. Amyloid 18:25\u201328","journal-title":"Amyloid"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13506120500232010","volume":"12","author":"S Inoue","year":"2005","unstructured":"Inoue S, Kawano H, Ishihara T, Maeda S, Ohno S (2005) Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study. Amyloid 12:157\u2013163","journal-title":"Amyloid"},{"key":"5_CR28","first-page":"439","volume":"23","author":"T Ishihara","year":"1973","unstructured":"Ishihara T (1973) Experimental amyloidosis using silver nitrate \u2013 electron microscopic study on the relationship between silver granules, amyloid fibrils and reticuloendothelial system. Acta Pathol Jpn 23:439\u2013464","journal-title":"Acta Pathol Jpn"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2007.05.015","volume":"469","author":"TR Jahn","year":"2008","unstructured":"Jahn TR, Radford SE (2008) Folding versus aggregation: polypeptide conformations on competing pathways. Arch Biochem Biophys 469:100\u2013117","journal-title":"Arch Biochem Biophys"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jmbi.2001.4863","volume":"311","author":"JL Jimenez","year":"2001","unstructured":"Jimenez JL, Tennent G, Pepys M, Saibil HR (2001) Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy. J Mol Biol 311:241\u2013247","journal-title":"J Mol Biol"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-biochem-060208-092442","volume":"82","author":"YE Kim","year":"2013","unstructured":"Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU (2013) Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 82:323\u2013355","journal-title":"Annu Rev Biochem"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jmb.2009.07.037","volume":"392","author":"AF Kintzer","year":"2009","unstructured":"Kintzer AF, Thoren KL, Sterling HJ, Dong KC, Feld GK, Tang II, Zhang TT, Williams ER, Berger JM, Krantz BA (2009) The protective antigen component of anthrax toxin forms functional octameric complexes. J Mol Biol 392:614\u2013629","journal-title":"J Mol Biol"},{"key":"5_CR33","first-page":"53","volume":"48","author":"R Kisilevsky","year":"1983","unstructured":"Kisilevsky R, Boudreau L (1983) Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy. Lab Invest 48:53\u201359","journal-title":"Lab Invest"},{"key":"5_CR34","first-page":"58","volume":"199","author":"R Kisilevsky","year":"1996","unstructured":"Kisilevsky R, Fraser P (1996) Proteoglycans and amyloid fibrillogenesis. Ciba Found Symp 199:58\u201367 (discussion 68-72, 90-103)","journal-title":"Ciba Found Symp"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/13506129.2011.654294","volume":"19","author":"R Kisilevsky","year":"2012","unstructured":"Kisilevsky R, Manley PN (2012) Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid 19:5\u201314","journal-title":"Amyloid"},{"key":"5_CR36","first-page":"778","volume":"66","author":"R Kisilevsky","year":"1992","unstructured":"Kisilevsky R, Subrahmanyan L (1992) Serum amyloid A changes high density lipoprotein\u2019s cellular affinity. A clue to serum amyloid A\u2019s principal function. Lab Invest 66:778\u2013785","journal-title":"Lab Invest"},{"key":"5_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sbi.2007.01.007","volume":"17","author":"R Kodali","year":"2007","unstructured":"Kodali R, Wetzel R (2007) Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol 17:48\u201357","journal-title":"Curr Opin Struct Biol"},{"key":"5_CR38","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361\u20132371","journal-title":"N Engl J Med"},{"key":"5_CR39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/01652176.1999.9694998","volume":"21","author":"WJ Landman","year":"1999","unstructured":"Landman WJ (1999) Amyloid arthropathy in chickens. Vet Q 21:78\u201382","journal-title":"Vet Q"},{"key":"5_CR40","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1172\/JCI107098","volume":"51","author":"M Levin","year":"1972","unstructured":"Levin M, Franklin EC, Frangione B, Pras M (1972) The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 51:2773\u20132776","journal-title":"J Clin Invest"},{"key":"5_CR41","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","volume":"102","author":"JP Li","year":"2005","unstructured":"Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, Metzger S, Vlodavsky I, Kisilevsky R, Lindahl U (2005) In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Proc Natl Acad Sci U S A 102:6473\u20136477","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR42","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0022-2275(20)37293-X","volume":"37","author":"JS Liang","year":"1996","unstructured":"Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, de Beer FC, Sipe JD (1996) Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 37:2109\u20132116","journal-title":"J Lipid Res"},{"key":"5_CR43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(97)00196-1","volume":"225","author":"JS Liang","year":"1997","unstructured":"Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD (1997) Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer\u2019s disease brain. Neurosci Lett 225:73\u201376","journal-title":"Neurosci Lett"},{"key":"5_CR44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0925-4439(94)00076-3","volume":"1270","author":"JJ Liepnieks","year":"1995","unstructured":"Liepnieks JJ, Kluve-Beckerman B, Benson MD (1995) Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta 1270:81\u201386","journal-title":"Biochim Biophys Acta"},{"key":"5_CR45","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","volume":"111","author":"J Lu","year":"2014","unstructured":"Lu J, Yu Y, Zhu I, Cheng Y, Sun PD (2014) Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci U S A 111:5189\u20135194","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR46","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1073\/pnas.092205999","volume":"99","author":"K Lundmark","year":"2002","unstructured":"Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A, Westermark P (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A 99:6979\u20136984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00018-008-8321-x","volume":"66","author":"E Malle","year":"2009","unstructured":"Malle E, Sodin-Semrl S, Kovacevic A (2009) Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci 66:9\u201326","journal-title":"Cell Mol Life Sci"},{"key":"5_CR48","doi-asserted-by":"crossref","first-page":"11248","DOI":"10.1021\/bi0491898","volume":"43","author":"M Manning","year":"2004","unstructured":"Manning M, Colon W (2004) Structural basis of protein kinetic stability: resistance to sodium dodecyl sulfate suggests a central role for rigidity and a bias toward beta-sheet structure. Biochemistry 43:11248\u201311254","journal-title":"Biochemistry"},{"key":"5_CR49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpc.2011.05.011","volume":"158","author":"DJ Martin","year":"2011","unstructured":"Martin DJ, Ramirez-Alvarado M (2011) Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction. Biophys Chem 158:81\u201389","journal-title":"Biophys Chem"},{"key":"5_CR50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.144.4.1121","volume":"144","author":"KP McAdam","year":"1976","unstructured":"McAdam KP, Sipe JD (1976) Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 144:1121\u20131127","journal-title":"J Exp Med"},{"key":"5_CR51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.163.3.499","volume":"163","author":"RL Meek","year":"1986","unstructured":"Meek RL, Hoffman JS, Benditt EP (1986) Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation. J Exp Med 163:499\u2013510","journal-title":"J Exp Med"},{"key":"5_CR52","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.91.8.3186","volume":"91","author":"RL Meek","year":"1994","unstructured":"Meek RL, Urieli-Shoval S, Benditt EP (1994) Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A 91:3186\u20133190","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR53","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret J-M, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781\u20131784","journal-title":"Science"},{"key":"5_CR54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/jb\/mvm144","volume":"142","author":"Y Miyagi","year":"2007","unstructured":"Miyagi Y, Matsumura Y, Sagami H (2007) Human geranylgeranyl diphosphate synthase is an octamer in solution. J Biochem 142:377\u2013381","journal-title":"J Biochem"},{"key":"5_CR55","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/bmj.290.6484.1797","volume":"290","author":"O Mutru","year":"1985","unstructured":"Mutru O, Laakso M, Isomaki H, Koota K (1985) Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 290:1797\u20131799","journal-title":"Br Med J (Clin Res Ed)"},{"key":"5_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/kei112","volume":"45","author":"T Nakamura","year":"2006","unstructured":"Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M (2006) Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford) 45:43\u201349","journal-title":"Rheumatology (Oxford)"},{"key":"5_CR57","doi-asserted-by":"crossref","first-page":"25669","DOI":"10.1074\/jbc.M112.363895","volume":"287","author":"F Noborn","year":"2012","unstructured":"Noborn F, Ancsin JB, Ubhayasekera W, Kisilevsky R, Li JP (2012) Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation. J Biol Chem 287:25669\u201325677","journal-title":"J Biol Chem"},{"key":"5_CR58","first-page":"w13580","volume":"142","author":"L Obici","year":"2012","unstructured":"Obici L, Merlini G (2012) AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med Wkly 142:w13580","journal-title":"Swiss Med Wkly"},{"issue":"Pt 3","key":"5_CR59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/bj3181041","volume":"318","author":"H Patel","year":"1996","unstructured":"Patel H, Bramall J, Waters H, De Beer MC, Woo P (1996) Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 318(Pt 3):1041\u20131049","journal-title":"Biochem J"},{"key":"5_CR60","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1021\/bi201903s","volume":"51","author":"S Patke","year":"2012","unstructured":"Patke S, Maheshwari R, Litt J, Srinivasan S, Aguilera JJ, Colon W, Kane RS (2012) Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation. Biochemistry 51:3092\u20133099","journal-title":"Biochemistry"},{"key":"5_CR61","doi-asserted-by":"crossref","first-page":"e64974","DOI":"10.1371\/journal.pone.0064974","volume":"8","author":"S Patke","year":"2013","unstructured":"Patke S, Srinivasan S, Maheshwari R, Srivastava SK, Aguilera JJ, Colon W, Kane RS (2013) Characterization of the oligomerization and aggregation of human serum amyloid a. PLoS One 8:e64974","journal-title":"PLoS One"},{"key":"5_CR62","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1021\/ja106044u","volume":"132","author":"R Pellarin","year":"2010","unstructured":"Pellarin R, Schuetz P, Guarnera E, Caflisch A (2010) Amyloid fibril polymorphism is under kinetic control. J Am Chem Soc 132:14960\u201314970","journal-title":"J Am Chem Soc"},{"key":"5_CR63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","volume":"57","author":"MB Pepys","year":"2006","unstructured":"Pepys MB (2006) Amyloidosis. Annu Rev Med 57:223\u2013241","journal-title":"Annu Rev Med"},{"key":"5_CR64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","volume":"440","author":"C Rocken","year":"2002","unstructured":"Rocken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111\u2013122","journal-title":"Virchows Arch"},{"key":"5_CR65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/jsbi.1997.3859","volume":"119","author":"B Seilheimer","year":"1997","unstructured":"Seilheimer B, Bohrmann B, Bondolfi L, Muller F, Stuber D, Dobeli H (1997) The toxicity of the Alzheimer\u2019s beta-amyloid peptide correlates with a distinct fiber morphology. J Struct Biol 119:59\u201371","journal-title":"J Struct Biol"},{"key":"5_CR66","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-3083.1987.tb02307.x","volume":"26","author":"M Shiroo","year":"1987","unstructured":"Shiroo M, Kawahara E, Nakanishi I, Migita S (1987) Specific deposition of serum amyloid A protein 2 in the mouse. Scand J Immunol 26:709\u2013716","journal-title":"Scand J Immunol"},{"key":"5_CR67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0950-3579(05)80119-0","volume":"8","author":"RW Simms","year":"1994","unstructured":"Simms RW, Prout MN, Cohen AS (1994) The epidemiology of AL and AA amyloidosis. Baillieres Clin Rheumatol 8:627\u2013634","journal-title":"Baillieres Clin Rheumatol"},{"key":"5_CR68","doi-asserted-by":"crossref","first-page":"16115","DOI":"10.1073\/pnas.1306621110","volume":"110","author":"JP Simons","year":"2013","unstructured":"Simons JP, Al-Shawi R, Ellmerich S, Speck I, Aslam S, Hutchinson WL, Mangione PP, Disterer P, Gilbertson JA, Hunt T, Millar DJ, Minogue S, Bodin K, Pepys MB, Hawkins PN (2013) Pathogenetic mechanisms of amyloid A amyloidosis. Proc Natl Acad Sci U S A 110:16115\u201316120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR69","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1146\/annurev.bi.61.070192.004503","volume":"61","author":"JD Sipe","year":"1992","unstructured":"Sipe JD (1992) Amyloidosis. Annu Rev Biochem 61:947\u2013975","journal-title":"Annu Rev Biochem"},{"key":"5_CR70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13506129908993291","volume":"6","author":"J Sipe","year":"1999","unstructured":"Sipe J (1999) Revised nomenclature for serum amyloid A (SAA). Nomenclature committee of the international society of amyloidosis. Part 2. Amyloid 6:67\u201370","journal-title":"Amyloid"},{"key":"5_CR71","first-page":"1480","volume":"143","author":"JD Sipe","year":"1993","unstructured":"Sipe JD, Carreras I, Gonnerman WA, Cathcart ES, de Beer MC, de Beer FC (1993) Characterization of the inbred CE\/J mouse strain as amyloid resistant. Am J Pathol 143:1480\u20131485","journal-title":"Am J Pathol"},{"key":"5_CR72","first-page":"420","volume":"36","author":"M Skinner","year":"1977","unstructured":"Skinner M, Shirahama T, Benson MD, Cohen AS (1977) Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 36:420\u2013427","journal-title":"Lab Invest"},{"key":"5_CR73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1432-1033.1974.tb03251.x","volume":"41","author":"K Sletten","year":"1974","unstructured":"Sletten K, Husby G (1974) The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem 41:117\u2013125","journal-title":"Eur J Biochem"},{"key":"5_CR74","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/39.10.1940305","volume":"39","author":"AD Snow","year":"1991","unstructured":"Snow AD, Bramson R, Mar H, Wight TN, Kisilevsky R (1991) A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 39:1321\u20131330","journal-title":"J Histochem Cytochem"},{"key":"5_CR75","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1021\/bi101905n","volume":"50","author":"JP Solomon","year":"2011","unstructured":"Solomon JP, Bourgault S, Powers ET, Kelly JW (2011) Heparin binds 8 kDa gelsolin cross-beta-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension. Biochemistry 50:2486\u20132498","journal-title":"Biochemistry"},{"key":"5_CR76","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1074\/jbc.M112.394155","volume":"288","author":"S Srinivasan","year":"2013","unstructured":"Srinivasan S, Patke S, Wang Y, Ye Z, Litt J, Srivastava SK, Lopez MM, Kurouski D, Lednev IK, Kane RS, Colon W (2013) Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2. J Biol Chem 288:2744\u20132755","journal-title":"J Biol Chem"},{"key":"5_CR77","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pneurobio.2012.03.002","volume":"99","author":"M Stefani","year":"2012","unstructured":"Stefani M (2012) Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer\u2019s disease and other diseases with amyloid deposits. Prog Neurobiol 99:226\u2013245","journal-title":"Prog Neurobiol"},{"key":"5_CR78","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2760(89)90192-6","volume":"1006","author":"A Steinmetz","year":"1989","unstructured":"Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC (1989) Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1006:173\u2013178","journal-title":"Biochim Biophys Acta"},{"key":"5_CR79","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1194\/jlr.M100388-JLR200","volume":"43","author":"SP Tam","year":"2002","unstructured":"Tam SP, Flexman A, Hulme J, Kisilevsky R (2002) Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. J Lipid Res 43:1410\u20131420","journal-title":"J Lipid Res"},{"key":"5_CR80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature04922","volume":"442","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442:585\u2013589","journal-title":"Nature"},{"key":"5_CR81","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/002215549804601206","volume":"46","author":"S Urieli-Shoval","year":"1998","unstructured":"Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y (1998) Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem 46:1377\u20131384","journal-title":"J Histochem Cytochem"},{"key":"5_CR82","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","volume":"7","author":"S Urieli-Shoval","year":"2000","unstructured":"Urieli-Shoval S, Linke RP, Matzner Y (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 7:64\u201369","journal-title":"Curr Opin Hematol"},{"key":"5_CR83","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.2741\/3594","volume":"14","author":"VN Uversky","year":"2009","unstructured":"Uversky VN (2009) Intrinsic disorder in proteins associated with neurodegenerative diseases. Front Biosci 14:5188\u20135238","journal-title":"Front Biosci"},{"key":"5_CR84","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbapap.2012.12.008","volume":"1834","author":"VN Uversky","year":"2013","unstructured":"Uversky VN (2013) Unusual biophysics of intrinsically disordered proteins. Biochim Biophys Acta 1834:932\u2013951","journal-title":"Biochim Biophys Acta"},{"key":"5_CR85","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1100\/tsw.2011.64","volume":"11","author":"JC Hilst van der","year":"2011","unstructured":"van der Hilst JC (2011) Recent insights into the pathogenesis of type AA amyloidosis. Sci World J 11:641\u2013650","journal-title":"Sci World J"},{"key":"5_CR86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MOL.0b013e328051b4fe","volume":"18","author":"DR Westhuyzen van der","year":"2007","unstructured":"van der Westhuyzen DR, de Beer FC, Webb NR (2007) HDL cholesterol transport during inflammation. Curr Opin Lipidol 18:147\u2013151","journal-title":"Curr Opin Lipidol"},{"key":"5_CR87","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1474-4422(03)00484-8","volume":"2","author":"J Horssen van","year":"2003","unstructured":"van Horssen J, Wesseling P, van den Heuvel LP, de Waal RM, Verbeek MM (2003) Heparan sulphate proteoglycans in Alzheimer\u2019s disease and amyloid-related disorders. Lancet Neurol 2:482\u2013492","journal-title":"Lancet Neurol"},{"key":"5_CR88","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1110\/ps.051387005","volume":"14","author":"L Wang","year":"2005","unstructured":"Wang L, Colon W (2005) Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer. Protein Sci 14:1811\u20131817","journal-title":"Protein Sci"},{"key":"5_CR89","doi-asserted-by":"crossref","first-page":"15947","DOI":"10.1073\/pnas.252508399","volume":"99","author":"L Wang","year":"2002","unstructured":"Wang L, Lashuel HA, Walz T, Colon W (2002) Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc Natl Acad Sci U S A 99:15947\u201315952","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13506120500223084","volume":"12","author":"L Wang","year":"2005","unstructured":"Wang L, Lashuel HA, Colon W (2005) From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature. Amyloid 12:139\u2013148","journal-title":"Amyloid"},{"key":"5_CR91","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbrc.2011.03.090","volume":"407","author":"Y Wang","year":"2011","unstructured":"Wang Y, Srinivasan S, Ye Z, Javier Aguilera J, Lopez MM, Colon W (2011) Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochem Biophys Res Commun 407:725\u2013729","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR92","doi-asserted-by":"crossref","first-page":"e39899","DOI":"10.1371\/journal.pone.0039899","volume":"7","author":"B Wang","year":"2012","unstructured":"Wang B, Tan YX, Jia J, Digre A, Zhang X, Vlodavsky I, Li JP (2012) Accelerated resolution of AA amyloid in heparanase knockout mice is associated with matrix metalloproteases. PLoS One 7:e39899","journal-title":"PLoS One"},{"key":"5_CR93","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-2275(20)37176-5","volume":"38","author":"NR Webb","year":"1997","unstructured":"Webb NR, de Beer MC, van der Westhuyzen DR, Kindy MS, Banka CL, Tsukamoto K, Rader DL, de Beer FC (1997) Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice. J Lipid Res 38:1583\u20131590","journal-title":"J Lipid Res"},{"key":"5_CR94","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-3083.1989.tb02468.x","volume":"30","author":"GT Westermark","year":"1989","unstructured":"Westermark GT, Sletten K, Westermark P (1989) Massive vascular AA-amyloidosis: a histologically and biochemically distinctive subtype of reactive systemic amyloidosis. Scand J Immunol 30:605\u2013613","journal-title":"Scand J Immunol"},{"key":"5_CR95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-291X(05)80107-X","volume":"182","author":"GT Westermark","year":"1992","unstructured":"Westermark GT, Engstrom U, Westermark P (1992) The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 182:27\u201333","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR96","doi-asserted-by":"crossref","first-page":"e6041","DOI":"10.1371\/journal.pone.0006041","volume":"4","author":"P Westermark","year":"2009","unstructured":"Westermark P, Lundmark K, Westermark GT (2009) Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model. PLoS One 4:e6041","journal-title":"PLoS One"},{"key":"5_CR97","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020712-163913","volume":"10","author":"GT Westermark","year":"2015","unstructured":"Westermark GT, Fandrich M, Westermark P (2015) AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol 10:321\u2013344","journal-title":"Annu Rev Pathol"},{"key":"5_CR98","doi-asserted-by":"crossref","first-page":"427296","DOI":"10.1155\/2012\/427296","volume":"2012","author":"M Woldemeskel","year":"2012","unstructured":"Woldemeskel M (2012) A concise review of amyloidosis in animals. Vet Med Int 2012:427296","journal-title":"Vet Med Int"},{"key":"5_CR99","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-3083.1995.tb03609.x","volume":"41","author":"T Yamada","year":"1995","unstructured":"Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD (1995) In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation. Scand J Immunol 41:570\u2013574","journal-title":"Scand J Immunol"},{"key":"5_CR100","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1021\/bi200856v","volume":"50","author":"Z Ye","year":"2011","unstructured":"Ye Z, Bayron Poueymiroy D, Aguilera JJ, Srinivasan S, Wang Y, Serpell LC, Colon W (2011) Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature. Biochemistry 50:9184\u20139191","journal-title":"Biochemistry"},{"key":"5_CR101","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1877-1173(10)93013-5","volume":"93","author":"X Zhang","year":"2010","unstructured":"Zhang X, Li JP (2010) Heparan sulfate proteoglycans in amyloidosis. Prog Mol Biol Transl Sci 93:309\u2013334","journal-title":"Prog Mol Biol Transl Sci"},{"key":"5_CR102","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1073\/pnas.0800367105","volume":"105","author":"B Zhang","year":"2008","unstructured":"Zhang B, Une Y, Fu X, Yan J, Ge F, Yao J, Sawashita J, Mori M, Tomozawa H, Kametani F, Higuchi K (2008) Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc Natl Acad Sci U S A 105:7263\u20137268","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Advances in Experimental Medicine and Biology","Lipids in Protein Misfolding"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-17344-3_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:12:47Z","timestamp":1652796767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-17344-3_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319173436","9783319173443"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-17344-3_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}